Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6524904 | 1.00 | KMT2A (0.44) | KMT2AMEN1GAAPOLBMAPT | |
| SCHEMBL2714124 | 0.78 | KMT2A (0.56) | KMT2AMEN1GAAPOLBMAPT | |
| SCHEMBL30862164 | 0.78 | MEN1 (0.38) | KMT2AMEN1MAPTLMNAAHR | |
| SCHEMBL26341085 | 0.78 | MEN1 (0.38) | KMT2AMEN1MAPTLMNAAHR | |
| SCHEMBL6073377 | 0.78 | MEN1 (0.38) | KMT2AMEN1GAAMAPTLMNA | |
| SCHEMBL24339632 | 0.78 | MEN1 (0.38) | KMT2AMEN1MAPTLMNAAHR | |
| SCHEMBL29537852 | 0.78 | MEN1 (0.38) | KMT2AMEN1GAAMAPTLMNA | |
| SCHEMBL3257090 | 0.77 | KMT2A (0.46) | KMT2AMEN1GAAPOLBMAPT | |
| SCHEMBL29545354 | 0.77 | MEN1 (0.43) | KMT2AMEN1LMNAAHRNPC1 | |
| SCHEMBL9910955 | 0.77 | MEN1 (0.43) | KMT2AMEN1LMNAAHRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843890-B | Application of triazolopyrimidine, triazolopyridine compound and composition thereof in treating PRC 2-mediated diseases | 中国科学院上海药物研究所 | 2022-03-29 | — | — | CN | claimed |
| CN-120077041-A | Tricyclic derivative compounds and use thereof | 韩美药品株式会社 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025084304-A1 | COMPOSITION, PREPREG, AND METAL-CLAD LAMINATED BOARD | ＡＧＣ株式会社 | 2025-04-24 | — | — | WO | disclosed |
| WO-2025084303-A1 | RESIN COMPOSITION, PREPREG, METAL-CLAD LAMINATE, AND METHOD FOR PRODUCING SAME | ＡＧＣ株式会社 | 2025-04-24 | — | — | WO | disclosed |
| CN-114269745-B | Heteroaryl substituted pyrazolopyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | 海帕瑞吉尼克斯股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-115703799-B | Azaaryl compounds, preparation method and application thereof | 上海青煜医药科技有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118745185-A | Imidazopyrimidines as EED inhibitors and use thereof | 密歇根大学董事会 | 2024-10-08 | — | — | CN | disclosed |
| CN-114127073-B | Imidazopyrimidines as EED inhibitors and use thereof | 密歇根大学董事会 | 2024-05-31 | — | — | CN | disclosed |
| EP-4237418-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | Blueprint Medicines Corporation (US) | 2023-09-06 | — | — | EP | disclosed |
| CN-115703799-A | Nitrogen heteroaryl compound, preparation method and application thereof | 上海青煜医药科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-112004845-B | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-05-31 | — | — | CN | disclosed |
| WO-2022094354-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | LENGO THERAPEUTICS, INC. (US) | 2022-05-05 | — | — | WO | disclosed |
| CN-114269745-A | Heteroaryl substituted pyrazolopyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | 海帕瑞吉尼克斯股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-109843890-B | Application of triazolopyrimidine, triazolopyridine compound and composition thereof in treating PRC 2-mediated diseases | 中国科学院上海药物研究所 | 2022-03-29 | — | — | CN | disclosed |